Download PDF
Thromb Haemost 2001; 86(05): 1144-1147
DOI: 10.1055/s-0037-1616042
In Focus
Schattauer GmbH

Analytical Considerations for Free Protein S Assays in Protein S Deficiency

Kristina E. M. Persson
1   Department of Clinical Chemistry, Lund University, University Hospital, Malmö, Sweden
,
Andreas Hillarp
1   Department of Clinical Chemistry, Lund University, University Hospital, Malmö, Sweden
,
Björn Dahlbäck
1   Department of Clinical Chemistry, Lund University, University Hospital, Malmö, Sweden
› Author AffiliationsThis work was supported by grants from the Research Funds at the University Hospital, Malmö.
Further Information

Publication History

Received 25 October 2000

Accepted after resubmission 12 June 2001

Publication Date:
13 December 2017 (online)

    Permissions and Reprints

Summary

Protein S is an anticoagulant protein that circulates in plasma in complex with C4b-binding protein (C4BP) or in free form. Deficiency of protein S increases the risk of venous thrombosis. Measurement of free protein S, as compared to total levels, has been shown to be superior for prediction of protein S deficiency. We studied the effects of different handling protocols for an immuno- and a ligand (C4BP)-based assay for free protein S. When the assay was performed at 37° C, the levels of free protein S in plasma from protein S deficient patients were approximately twice those obtained at room temperature. The reason for this phenomenon was that plasmas from protein S deficient patients exhibited a time-, temperature-, and dilution-dependent increase in free protein S, which was more pronounced than corresponding dilution of the normal plasma that was used to create the standard curve. These findings demonstrate the importance of assay procedure and sample handling in assays for free protein S.

Keywords

Protein S - C4BP - complex - assay - coagulation
 

  • References

  • 1 Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-4.
    PubMedGoogle Scholar
  • 2 Walker FJ. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128-31.
    PubMedGoogle Scholar
  • 3 Koedam JA, Meijers JC, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-43.
    CrossrefPubMedGoogle Scholar
  • 4 Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor V by activated protein C. Protein S modulates factor Xa protection. J Biol Chem 1988; 263: 14884-90.
    PubMedGoogle Scholar
  • 5 Jane SM, Hau L, Salem HH. Regulation of activated protein C by factor Xa. Blood Coagul Fibrinolysis 1991; 2: 723-9.
    CrossrefPubMedGoogle Scholar
  • 6 Rosing J, Hoekema L, Nicolaes GA. et al. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 27852-8.
    CrossrefPubMedGoogle Scholar
  • 7 Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-7.
    PubMedGoogle Scholar
  • 8 Hackeng TM, van’t Veer C, Meijers JC, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem 1994; 269: 21051-8.
    PubMedGoogle Scholar
  • 9 Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 1994; 91: 2728-32.
    CrossrefPubMedGoogle Scholar
  • 10 Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-7.
    PubMedGoogle Scholar
  • 11 He X, Shen L, Malmborg A-C, Smith KJ, Dahlbäck B, Linse S. Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin-G-type repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance. Biochemistry 1997; 36: 3745-54.
    CrossrefPubMedGoogle Scholar
  • 12 Zöller B, Garcia de Frutos P, Hillarp A, Dahlbäck B. Thrombophilia as a multigenic disease. Haematologia 1999; 84: 59-70.
    PubMedGoogle Scholar
  • 13 Meijer P, Oerle R v, de Weerd B, den Dool E-J, Verbruggen B. The contribution of the type of calibrator to the variability of the total and free protein S antigen measurement. Haemostasis 2000; 30: 38-9.
    PubMedGoogle Scholar
  • 14 Zöller B, Garcia de Frutos P, Dahlbäck B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995; 85: 3524-31.
    PubMedGoogle Scholar
  • 15 Giri TG, Hillarp A, Härdig Y, Zöller B, Dahlbäck B. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen. Thromb Haemost 1998; 79: 767-72.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Dahlbäck B, Hildebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem 1990; 265: 8127-35.
    PubMedGoogle Scholar
  • 17 Rezende SM, Simmonds RE, Zöller B, Dahlbäck B, Lane DA. The molecular basis of type I/III protein S deficincy. Thromb Haemost. 1999 (supplement) abstract 1349: 426-7.
    PubMedGoogle Scholar